ReviewOncotarget2016
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr.
Patrizia Mondello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewOncotarget2016
Patrizia Mondello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.